Ryan Potts

Ryan Potts

Company: Amgen

Job title: Executive Director & Head of IPP

Seminars:

Tissue-Specific Ubiquitin Ligases for Targeted Protein Degradation 3:50 pm

Targeted protein degradation (TPD) is an exciting new drug modality to unlock the undruggable genome Degradation of target proteins of interest in select tissues will enable broader applications for TPD Tissue-specific E3 ubiquitin ligases offer an opportunity for selective target degradationRead more

day: Day One

Live Panel Q&A – Ask the Speakers Your Burning Questions! 4:15 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.